Diabetic iris neovascularization. Natural history and treatment

Acta Ophthalmologica Scandinavica

Volumn 75, Issue 1, 1997, Pages 89-93

  Fernández Vigo, Jose ^a,b   Castro, Juan ^a   Macarro, Ana ^a  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b Facultad de Medicina   (Spain)

Author keywords

Cryotherapy; Diabetes mellitus; Diabetic iris neovascularization; Diabetic retinopathy; Laser; Neovascular glaucoma; Treatment

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CRYOTHERAPY; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; IRIS; IRIS DISEASE; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; NEOVASCULAR GLAUCOMA; NEOVASCULARIZATION (PATHOLOGY); PRIORITY JOURNAL; TIME;

EID: 1842329180     PISSN: 13953907     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0420.1997.tb00258.x     Document Type: Article

References (19)

1. Bonnet M, Jourdain M & Francoz-Taillanter N (1981): Corrélation néovaisseaux papillaires-rubeosis iridis. J Fr Ophthalmol 5: 405-410.
2. Brodell LP, Olk RJ & Arribas NP (1987): Neovascular glaucoma: A retrospective analysis of treatment with peripheral panretinal cryotherapy. Ophthalmic Surgery 18: 200-216.
3. Cooper KL & Constable IJ (1989): The management of neovascular glaucoma. Aust J Ophthalmol 7/1: 5-9.
4. Doft BH & Blankenship GW (1982): Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 89: 772-779.
5. Fernández-Vigo J, Castro J, Cordido M & Sabugal JF (1988): Treatment of diabetic neovascular glaucoma by panretinal ablation and trabeculectomy. Acta Ophthalmol (Copenh) 66: 612-616.
6. Gartner S & Henkind P. (1978): Neovascularization of the iris (Rubeosis iridis). Surv Ophthalmol 22: 291-312.
7. Henkind P (1978): Ocular neovascularization. Am J Ophthalmol 85: 287-301.
8. Krill AE (1971): Photocoagulation in complications secondary to branch vein occlusion. Am J Ophthalmol 85: 48-53.
9. Laatikainen L (1979): Development and classification of Rubeosis iridis in diabetic eye disease. Br J Ophthalmol 63: 150-156.
10. Little HL, Rosenthal AR, Dellaporta A & Jacobson DR (1976): The effect of pan-retinal photocoagulation on rubeosis iridis. Am J Ophthalmol 81: 804-809.
11. Madsen PH (1971a): Haemorrhagic glaucoma. Comparative study in diabetic and non-diabetic patients. Br J Ophthalmol 55: 444-450.
12. Madsen PH (1971b); Rubeosis of the iris and haemorrhagic glaucoma in patients with proliferative diabetic retinopathy. Br J Ophthalmol 55: 368-371.
13. May DR, Bergstrom TJ, Parmet AJ & Schwartz JG (1980): Treatment of neovascular glaucoma with transscleral panretinalcryoteraphy. Ophthalmology 87: 1106-1111.
14. Murphy RP & Egbert PR (1979): Regression of iris neovascularization following panretinal photocoagulation. Arch Ophthalmol 97: 700-702.
15. Orth V (1971): The frequency of rubeosis iridis in diabetic patients. Acta Ophthalmol (Copenh) 49: 301-307.
16. Pavan PR, Folk JC & Weingeist TA (1983): Diabetic rubeosis and panretinal photocoagulation. Arch Ophthalmol 101: 882-884.
17. Sjölie AK (1985): Ocular complications of insulin treated diabetes mellitus. An epidemiological study. Acta Ophthalmol (Copenh) 63: (Suppl 172).
18. Tasman W, Magargal LE & Augsburger JJ (1980): Effects of argon laser photocoagulation on rubeosis iridis and angle neovascularization. Ophthalmology 87: 400-402.
19. Vernon SA & Cheng H (1988): Panretinal cryotherapy in neovascular disease. Br J Ophthalmol 72: 401-405.